These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10977477)

  • 1. The clinical and economic burden of obesity in a managed care setting.
    Oster G; Edelsberg J; O'Sullivan AK; Thompson D
    Am J Manag Care; 2000 Jun; 6(6):681-9. PubMed ID: 10977477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost of obesity in Canada.
    Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
    CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of obesity-related chronic diseases in Mainland China.
    Zhao W; Zhai Y; Hu J; Wang J; Yang Z; Kong L; Chen C
    Obes Rev; 2008 Mar; 9 Suppl 1():62-7. PubMed ID: 18307701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Swedish cost burden of overweight and obesity--evaluated with the PAR approach and a statistical modelling approach.
    Odegaard K; Borg S; Persson U; Svensson M
    Int J Pediatr Obes; 2008; 3 Suppl 1():51-7. PubMed ID: 18278633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic impact of obesity. Building bridges with managed care.
    Wolf AM
    Postgrad Med; 2001 Jun; 109(6 Suppl):34-9. PubMed ID: 19667566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of disease attributable to obesity and overweight in Korea.
    Park JH; Yoon SJ; Lee H; Jo HS; Lee SI; Kim Y; Kim YI; Shin Y
    Int J Obes (Lond); 2006 Nov; 30(11):1661-9. PubMed ID: 16534516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and economic effects of coronary restenosis after percutaneous coronary intervention in a managed care population.
    Clark MA; Bakhai A; Pelletier EM; Cohen DJ
    Manag Care; 2005 Apr; 14(4):42-4, 46-51. PubMed ID: 15898211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
    Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
    Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of metabolic syndrome-related diseases induced by obesity in Taiwan.
    Fu T; Wen T; Yeh P; Chang H
    Obes Rev; 2008 Mar; 9 Suppl 1():68-73. PubMed ID: 18307702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
    Birnbaum HG; Kessler RC; Lowe SW; Secnik K; Greenberg PE; Leong SA; Swensen AR
    Curr Med Res Opin; 2005 Feb; 21(2):195-206. PubMed ID: 15801990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health economics of weight management: evidence and cost.
    Kouris-Blazos A; Wahlqvist ML
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():329-38. PubMed ID: 17392129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care.
    Yelin E; Herrndorf A; Trupin L; Sonneborn D
    Arthritis Rheum; 2001 May; 44(5):1160-9. PubMed ID: 11352250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and overweight in Canada: an updated cost-of-illness study.
    Anis AH; Zhang W; Bansback N; Guh DP; Amarsi Z; Birmingham CL
    Obes Rev; 2010 Jan; 11(1):31-40. PubMed ID: 19413707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.